Hayden Royal’s Abiomed Inc ABMD Stock Holding History

Hayden Royal’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,432	Closed	-$1.78M	–	585
2020 Q3	$1.78M	Buy	+6,432	New	+$1.85M	0.95%	25

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Hayden Royal's ABMD Position: Q4 2020 in Review

Hayden Royal sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 6,432 shares — an estimated $1.78M sold.

Hayden Royal first reported a position in ABMD in Q3 2020 and held it in 1 quarter. The position peaked at $1.78M in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

Hayden Royal reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
Hayden Royal sold 6,432 Abiomed Inc shares in Q4 2020, an estimated $1.78M.
Hayden Royal first reported a position in Abiomed Inc in Q3 2020 and held it in 1 quarter.
Hayden Royal's Abiomed Inc position peaked at $1.78M in Q3 2020.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Hayden Royal's 13F filing for Q4 2020, filed 16 Feb 2021.